Growth Metrics

Plus Therapeutics (PSTV) Gains from Investment Securities (2016 - 2025)

Plus Therapeutics has reported Gains from Investment Securities over the past 15 years, most recently at $125814.0 for Q4 2025.

  • Quarterly Gains from Investment Securities changed N/A to $125814.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $125814.0 through Dec 2025, down 94.69% year-over-year, with the annual reading at $125814.0 for FY2025, 78.98% down from the prior year.
  • Gains from Investment Securities was $125814.0 for Q4 2025 at Plus Therapeutics, down from $11.3 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $11.3 million in Q3 2025 and troughed at -$2000.0 in Q3 2021.
  • The 5-year median for Gains from Investment Securities is $145803.5 (2023), against an average of $1.1 million.
  • Year-over-year, Gains from Investment Securities crashed 100.38% in 2021 and then skyrocketed 756264.71% in 2023.
  • A 5-year view of Gains from Investment Securities shows it stood at $1.2 million in 2021, then skyrocketed by 102.41% to $2.4 million in 2022, then plummeted by 99.76% to $5679.0 in 2023, then soared by 10439.53% to $598540.0 in 2024, then plummeted by 78.98% to $125814.0 in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Gains from Investment Securities are $125814.0 (Q4 2025), $11.3 million (Q3 2025), and $707088.0 (Q2 2025).